Hepatitis C - Schering-Plough Has Profit

Schering-Plough Has Profit
Street.Com - Fourth quarter sales growth was driven by prescription pharmaceuticals, Peg-Intron, Rebetol, Nasonex and Remicade. The sales growth versus 2004 includes a 3% unfavorable impact from foreign exchange. Fourth quarter 2005 GAAP net sales of Prescription

Schering-Plough posts profit, key drugs deliver
ABC News - NEW YORK (Reuters) - Schering-Plough Corp. on Monday reported a fourth-quarter profit, compared with a year-ago loss, helped by lower taxes and sales growth of its drugs for arthritis, hepatitis C and allergies. But the stock fell 1.4 percent

Killer told dozen-plus renditions of shooting
Fort Wayne Journal Gazette - AUBURN In a two-hour rambling statement to police, accused murderer David Barany changed his story multiple times about the fatal shooting of a friend. Jurors watched video of Barany s statement during the fourth day of his murder trial

Inzy, Malik ruled out of second Test
Hindustan Times - Pakistani opener Shoaib Malik has been ruled out of the ongoing second Test against India here while captain Inzamam-ul-Haq will not field in the match due to back problems, the team manager said on Monday. Team manager Muhammed Ahmed said Malik left